Results 81 to 90 of about 599,694 (181)
Withaferin A reduces pulmonary eosinophilia and IL-25 production in a mouse model of allergic airways disease. [PDF]
Agner K +5 more
europepmc +2 more sources
An unusual cause of progressive dyspnoea, pulmonary nodules and pleural effusions
Eosinophilic granulomatosis with polyangiitis (EGPA) is part of the ANCA‐associated vasculitides, although ANCA‐negative presentations are not infrequent.
Sudharsan Venkatesan +3 more
doaj +1 more source
Pulmonary membrane diffusing capacity and capillary blood volume in tropical eosinophilia
Pulmonary membrane diffusing capacity (Dm) and pulmonary capillary blood volume (Vc) measurements were carried out in 21 patients with untreated tropical eosinophilia and 21 healthy controls matched for age, sex, height, and smoking habit.
Sankaran, K +4 more
core +1 more source
Tropical pulmonary eosinophilia and filariasis in Pakistan
Filariasis is a major health problem in South Asia, particularly India, Sri Lanka and Bangladesh. Pakistan was presumed to be not affected. We report for the first time confirmed cases of tropical pulmonary eosinophilia (TPE) in indigenous patients as a ...
Naqvi, A, Beg, M A, Hussain, R, Zaman, V
core
Pulmonary eosinophilia associated to treatment with natalizumab
Natalizumab (Tysabri ®) is a leukocytes chemotaxis inhibitor that decreases the leukocytes passage through the hematoencephalic barrier and it is currently used in relapsing-remitting forms of multiple sclerosis (MS).
Munteis-Olivas, Elvira +4 more
core
Pulmonary eosinophilia comprises a heterogeneous group of diseases defined by eosinophilia in pulmonary infiltrates (bronchoalveolar lavage fluid) or in tissue (lung biopsy specimens). Although the inflammatory infiltrate is composed of macrophages, lymphocytes, neutrophils and eosinophils, eosinophilia is an important marker for the diagnosis and ...
Luiz Eduardo Mendes, Campos +1 more
openaire +1 more source

